NASDAQ:ALXN - Alexion Pharmaceuticals SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$128.91 -0.51 (-0.39 %)
(As of 02/19/2019 04:00 PM ET)
Previous Close$129.42
Today's Range$128.12 - $129.67
52-Week Range$92.56 - $140.77
Volume43,453 shs
Average Volume1.86 million shs
Market Capitalization$28.81 billion
P/E Ratio18.18
Dividend YieldN/A
Beta1.56

SEC Filings

Alexion Pharmaceuticals (NASDAQ:ALXN) SEC Filings

DateFilerForm TypeView
02/14/2019
12:48 PM
Alexion Pharmaceuticals (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G/A
View Filing
02/12/2019
11:10 AM
Alexion Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
View Filing
02/11/2019
5:39 PM
Alexion Pharmaceuticals (Issuer)
HANTSON LUDWIG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/11/2019
5:21 PM
Alexion Pharmaceuticals (Issuer)
Clancy Paul J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/11/2019
5:20 PM
Alexion Pharmaceuticals (Issuer)
Goff Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/11/2019
5:18 PM
Alexion Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/11/2019
9:30 AM
Alexion Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
View Filing
02/06/2019
8:03 AM
Alexion Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
02/04/2019
9:09 AM
Alexion Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
View Filing
02/04/2019
5:37 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/03/2019
5:07 PM
Alexion Pharmaceuticals (Issuer)
HANTSON LUDWIG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/21/2018
10:29 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/17/2018
11:00 AM
Alexion Pharmaceuticals (Filer)
Form CT ORDER
View Filing
11/30/2018
5:15 PM
Alexion Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/16/2018
5:10 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/13/2018
9:38 AM
Alexion Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SC 13G/A
View Filing
10/24/2018
3:27 PM
Alexion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
10/24/2018
5:46 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/01/2018
4:26 PM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/14/2018
4:20 PM
Alexion Pharmaceuticals (Filer)
Form S-3ASR
View Filing
07/26/2018
3:40 PM
Alexion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
07/26/2018
5:55 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/12/2018
4:23 PM
Alexion Pharmaceuticals (Issuer)
Clancy Paul J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/13/2018
5:03 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/12/2018
3:52 PM
Alexion Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/12/2018
3:51 PM
Alexion Pharmaceuticals (Issuer)
LAW ANNE-MARIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/12/2018
3:51 PM
Alexion Pharmaceuticals (Issuer)
Goff Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/12/2018
3:51 PM
Alexion Pharmaceuticals (Issuer)
ORLOFF JOHN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/11/2018
9:19 AM
Alexion Pharmaceuticals (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G/A
View Filing
05/11/2018
3:44 PM
667, L.P. (Reporting)
Alexion Pharmaceuticals (Issuer)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/11/2018
3:16 PM
Alexion Pharmaceuticals (Issuer)
Brennan David R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/11/2018
3:15 PM
Alexion Pharmaceuticals (Issuer)
Reinsdorf Judith A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/11/2018
3:14 PM
Alexion Pharmaceuticals (Issuer)
COUGHLIN CHRISTOPHER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/11/2018
3:13 PM
Alexion Pharmaceuticals (Issuer)
Dunsire Deborah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/11/2018
3:12 PM
Alexion Pharmaceuticals (Issuer)
Rummelt Andreas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/11/2018
3:12 PM
Alexion Pharmaceuticals (Issuer)
Nader Francois (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/11/2018
3:11 PM
Alexion Pharmaceuticals (Issuer)
Mollen John T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/11/2018
3:10 PM
Alexion Pharmaceuticals (Issuer)
FRIEDMAN PAUL A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/11/2018
3:09 PM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/02/2018
4:42 PM
Alexion Pharmaceuticals (Issuer)
COUGHLIN CHRISTOPHER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/26/2018
3:05 PM
Alexion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
04/26/2018
8:15 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/11/2018
3:27 PM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/28/2018
4:24 PM
Alexion Pharmaceuticals (Filer)
Form DEFA14A
View Filing
03/28/2018
4:23 PM
Alexion Pharmaceuticals (Filer)
Form DEF 14A
View Filing
03/02/2018
4:02 PM
Alexion Pharmaceuticals (Issuer)
Clancy Paul J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/02/2018
4:02 PM
Alexion Pharmaceuticals (Issuer)
LAW ANNE-MARIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/02/2018
4:01 PM
Alexion Pharmaceuticals (Issuer)
Chiniara Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/02/2018
4:01 PM
Alexion Pharmaceuticals (Issuer)
HANTSON LUDWIG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/02/2018
4:01 PM
Alexion Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/02/2018
4:00 PM
Alexion Pharmaceuticals (Issuer)
ORLOFF JOHN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/02/2018
4:00 PM
Alexion Pharmaceuticals (Issuer)
Goff Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/02/2018
3:59 PM
Alexion Pharmaceuticals (Issuer)
O'Neill Julie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/01/2018
4:25 PM
Alexion Pharmaceuticals (Issuer)
O'Neill Julie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/01/2018
4:25 PM
Alexion Pharmaceuticals (Issuer)
Wagner Heidi L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/22/2018
3:55 PM
Alexion Pharmaceuticals (Issuer)
Chiniara Ellen (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
02/14/2018
12:58 PM
Alexion Pharmaceuticals (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G/A
View Filing
02/13/2018
12:11 PM
Alexion Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
View Filing
02/13/2018
8:33 AM
Alexion Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SC 13G/A
View Filing
02/12/2018
8:07 AM
Alexion Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
View Filing
02/08/2018
6:17 PM
Alexion Pharmaceuticals (Issuer)
Goff Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/08/2018
6:17 PM
Alexion Pharmaceuticals (Issuer)
Wagner Heidi L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/08/2018
6:17 PM
Alexion Pharmaceuticals (Issuer)
Clancy Paul J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/08/2018
6:16 PM
Alexion Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/08/2018
6:16 PM
Alexion Pharmaceuticals (Issuer)
O'Neill Julie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/08/2018
6:16 PM
Alexion Pharmaceuticals (Issuer)
Moriarty John B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/08/2018
6:16 PM
Alexion Pharmaceuticals (Issuer)
HANTSON LUDWIG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/08/2018
6:15 PM
Alexion Pharmaceuticals (Issuer)
Reinsdorf Judith A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/08/2018
6:15 PM
Alexion Pharmaceuticals (Issuer)
Dunsire Deborah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/08/2018
6:15 PM
Alexion Pharmaceuticals (Issuer)
Reinsdorf Judith A (Reporting)
Form 3/A
View Filing
02/08/2018
3:26 PM
Alexion Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
02/08/2018
3:16 PM
Alexion Pharmaceuticals (Issuer)
Reinsdorf Judith A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
02/08/2018
8:19 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/01/2018
4:30 PM
Alexion Pharmaceuticals (Issuer)
Dunsire Deborah (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
01/29/2018
3:38 PM
Alexion Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
View Filing
01/22/2018
3:50 PM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/04/2018
5:33 PM
Alexion Pharmaceuticals (Issuer)
HANTSON LUDWIG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/05/2017
5:05 PM
Alexion Pharmaceuticals (Issuer)
COUGHLIN CHRISTOPHER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/30/2017
3:12 PM
Alexion Pharmaceuticals (Issuer)
FRIEDMAN PAUL A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/30/2017
3:12 PM
Alexion Pharmaceuticals (Issuer)
Nader Francois (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
This page was last updated on 2/19/2019 by MarketBeat.com Staff

Featured Article: Channel Trading

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel